Westpac Banking Corp Penumbra Inc Transaction History

Westpac Banking Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$175.6 - $291.43 $5.94 Million - $9.86 Million	-33,844 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$174.98 - $272.83 $34,996 - $54,566	-200 Reduced 0.59%	33,844 $5.92 Million
Q3 2020 Nov 10, 2020	BUY	$185.27 - $238.73 $18,527 - $23,873	100 Added 0.29%	34,044 $6.62 Million
Q2 2020 Aug 12, 2020	SELL	$153.32 - $191.72 $315,225 - $394,176	-2,056 Reduced 5.71%	33,944 $6.07 Million
Q1 2020 May 14, 2020	SELL	$124.34 - $193.76 $1.39 Million - $2.17 Million	-11,200 Reduced 23.73%	36,000 $5.81 Million
Q3 2019 Nov 13, 2019	BUY	$131.82 - $183.4 $540,462 - $751,940	4,100 Added 9.51%	47,200 $6.35 Million
Q2 2019 Aug 01, 2019	BUY	$124.65 - $167.39 $5.37 Million - $7.21 Million	43,100 New	43,100 $0

409

29.2M

254K

43.3K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.1B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Westpac Banking Corp with notifications on news.